Bernstein Starts Guangdong Marubi Biotechnology Co Ltd (603983:CH) at Market Perform
- S&P 500, Nasdaq up on tech gains; unfazed by vaccine pause, inflation
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Oil rises 1% after robust China data but J&J vaccine pause weighs
- Bitcoin (BTC) Price Soars 5% to Fresh Record Highs Ahead of Coinbase IPO
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Bernstein analyst Melinda Hu initiates coverage on Guangdong Marubi Biotechnology Co Ltd (603983:CH) with a Market Perform rating and a price target of RMB61.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Jefferies Starts Finch Therapeutics Group Inc. (FNCH) at Buy
- Goldman Sachs Upgrades Kubota Corp (6326:JP) (KUBTY) to Buy
- Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR4.30 at Goldman Sachs, Ahead Of Earnings